Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Vishal S. Vaidya, Ph.D.

Co-Author

This page shows the publications co-authored by Vishal Vaidya and Joseph Bonventre.
Connection Strength

4.459
  1. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-ß-D-glucosaminidase. Kidney Int. 2011 Feb; 79(4):464-70.
    View in: PubMed
    Score: 0.451
  2. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol. 2010 May; 28(5):478-85.
    View in: PubMed
    Score: 0.436
  3. A rapid urine test for early detection of kidney injury. Kidney Int. 2009 Jul; 76(1):108-14.
    View in: PubMed
    Score: 0.406
  4. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2008 Dec; 1(3):200-8.
    View in: PubMed
    Score: 0.395
  5. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol. 2008; 48:463-93.
    View in: PubMed
    Score: 0.371
  6. Mechanistic biomarkers for cytotoxic acute kidney injury. Expert Opin Drug Metab Toxicol. 2006 Oct; 2(5):697-713.
    View in: PubMed
    Score: 0.340
  7. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol. 2006 Feb; 290(2):F517-29.
    View in: PubMed
    Score: 0.317
  8. Therapeutic silencing of SMOC2 prevents kidney function loss in mouse model of chronic kidney disease. iScience. 2021 Oct 22; 24(10):103193.
    View in: PubMed
    Score: 0.240
  9. Environmental exposure to arsenic and chromium in children is associated with kidney injury molecule-1. Environ Res. 2016 10; 150:653-662.
    View in: PubMed
    Score: 0.168
  10. TIM2 gene deletion results in susceptibility to cisplatin-induced kidney toxicity. Toxicol Sci. 2010 Nov; 118(1):298-306.
    View in: PubMed
    Score: 0.111
  11. Next-generation biomarkers for detecting kidney toxicity. Nat Biotechnol. 2010 May; 28(5):436-40.
    View in: PubMed
    Score: 0.109
  12. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int. 2010 Apr; 77(8):708-14.
    View in: PubMed
    Score: 0.106
  13. Preclinical evaluation of novel urinary biomarkers of cadmium nephrotoxicity. Toxicol Appl Pharmacol. 2009 Aug 01; 238(3):301-5.
    View in: PubMed
    Score: 0.100
  14. Expression of kidney injury molecule-1 (Kim-1) in relation to necrosis and apoptosis during the early stages of Cd-induced proximal tubule injury. Toxicol Appl Pharmacol. 2009 Aug 01; 238(3):306-14.
    View in: PubMed
    Score: 0.100
  15. Biomarkers of nephrotoxic acute kidney injury. Toxicology. 2008 Mar 20; 245(3):182-93.
    View in: PubMed
    Score: 0.093
  16. Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity. Kidney Int. 2007 Oct; 72(8):985-93.
    View in: PubMed
    Score: 0.090
  17. Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol. 2006 Nov 01; 177(9):5902-11.
    View in: PubMed
    Score: 0.085
  18. Structural equation modeling highlights the potential of Kim-1 as a biomarker for chronic kidney disease. Am J Nephrol. 2012; 35(2):152-63.
    View in: PubMed
    Score: 0.031
  19. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int. 2011 May; 79(10):1119-30.
    View in: PubMed
    Score: 0.029
  20. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol. 2010 Dec; 5(12):2154-65.
    View in: PubMed
    Score: 0.028
  21. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart. 2010 Aug; 96(16):1297-302.
    View in: PubMed
    Score: 0.028
  22. Age-related differences in susceptibility to cisplatin-induced renal toxicity. J Appl Toxicol. 2010 Mar; 30(2):172-82.
    View in: PubMed
    Score: 0.027
  23. Performance of novel kidney biomarkers in preclinical toxicity studies. Toxicol Sci. 2010 Jul; 116(1):8-22.
    View in: PubMed
    Score: 0.027
  24. Differences in immunolocalization of Kim-1, RPA-1, and RPA-2 in kidneys of gentamicin-, cisplatin-, and valproic acid-treated rats: potential role of iNOS and nitrotyrosine. Toxicol Pathol. 2009 Aug; 37(5):629-43.
    View in: PubMed
    Score: 0.026
  25. Kidney injury molecule-1 is an early noninvasive indicator for donor brain death-induced injury prior to kidney transplantation. Am J Transplant. 2009 Aug; 9(8):1752-9.
    View in: PubMed
    Score: 0.026
  26. Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity. Toxicol Sci. 2009 Jun; 109(2):336-49.
    View in: PubMed
    Score: 0.025
  27. Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time. Am J Physiol Renal Physiol. 2009 May; 296(5):F1136-45.
    View in: PubMed
    Score: 0.025
  28. Modulation of aquaporin-2/vasopressin2 receptor kidney expression and tubular injury after endotoxin (lipopolysaccharide) challenge. Crit Care Med. 2008 Nov; 36(11):3054-61.
    View in: PubMed
    Score: 0.025
  29. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial. Am J Kidney Dis. 2009 Jan; 53(1):16-25.
    View in: PubMed
    Score: 0.024
  30. Renoprotective mechanisms of soy protein intake in the obese Zucker rat. Am J Physiol Renal Physiol. 2008 Nov; 295(5):F1574-82.
    View in: PubMed
    Score: 0.024
  31. Immunolocalization of Kim-1, RPA-1, and RPA-2 in kidney of gentamicin-, mercury-, or chromium-treated rats: relationship to renal distributions of iNOS and nitrotyrosine. Toxicol Pathol. 2008 Apr; 36(3):397-409.
    View in: PubMed
    Score: 0.024
  32. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation. 2007 Dec 27; 84(12):1625-30.
    View in: PubMed
    Score: 0.023
  33. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci. 2008 Jan; 101(1):159-70.
    View in: PubMed
    Score: 0.023
  34. Increased susceptibility of aging kidney to ischemic injury: identification of candidate genes changed during aging, but corrected by caloric restriction. Am J Physiol Renal Physiol. 2007 Oct; 293(4):F1272-81.
    View in: PubMed
    Score: 0.023
  35. The utility of a rodent model in detecting pediatric drug-induced nephrotoxicity. Toxicol Sci. 2007 Oct; 99(2):637-48.
    View in: PubMed
    Score: 0.022
  36. Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol. 2007 Mar; 18(3):904-12.
    View in: PubMed
    Score: 0.022
  37. Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase. Am J Physiol Renal Physiol. 2007 Jan; 292(1):F313-20.
    View in: PubMed
    Score: 0.021
  38. Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity. Am J Physiol Renal Physiol. 2007 Jan; 292(1):F131-9.
    View in: PubMed
    Score: 0.021
  39. Tubular kidney injury molecule-1 in protein-overload nephropathy. Am J Physiol Renal Physiol. 2006 Aug; 291(2):F456-64.
    View in: PubMed
    Score: 0.020
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.